Variation of maternal KIR and fetal HLA-C genes in reproductive failure: too early for clinical intervention

Reproductive BioMedicine Online

Volumn 33, Issue 6, 2016, Pages 763-769

  Moffett, Ashley ^a   Chazara, Olympe ^a   Colucci, Francesco ^a   Johnson, Martin H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

HLA C; KIR; natural killer (NK) cells; placental disorders; tissue typing; trophoblast

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; EPITOPE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KIR2DL1 PROTEIN, HUMAN; LIGAND;

FEMALE; FEMALE INFERTILITY; GENETIC VARIATION; GENITAL SYSTEM DISEASE; HLA SYSTEM; HUMAN; INTERVENTION STUDY; NATURAL KILLER CELL; NOTE; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; RECURRENT ABORTION; SPERM DONOR; SPONTANEOUS ABORTION; TROPHOBLAST; ABORTION, HABITUAL; CHEMISTRY; COHORT ANALYSIS; DECIDUA; GENETIC RECOMBINATION; GENETICS; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; INFERTILITY; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; REPRODUCTION; UTERUS;

ABORTION, HABITUAL; COHORT STUDIES; DECIDUA; EPITOPES; FEMALE; GENOTYPE; HAPLOTYPES; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; INFERTILITY; KILLER CELLS, NATURAL; LIGANDS; PLACENTA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, KIR2DL1; RECOMBINATION, GENETIC; REPRODUCTION; TROPHOBLASTS; UTERUS;

EID: 84991240671     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2016.08.019     Document Type: Note

References (24)

1. Alecsandru, D., Garrido, N., Vicario, J.L., Barrio, A., Aparicio, P., Requena, A., García-Velasco, J.A., Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum. Reprod 29 (2014), 2637–2643.
2. Basso, O., Weinberg, C.R., Baird, D.D., Wilcox, A.J., Olsen, J., Subfecundity as a Correlate of Preeclampsia: a study within the Danish National Birth Cohort. Am. J. Epidemiol 157 (2003), 195–202.
3. Brosens, I., Pijnenborg, R., Vercruysse, L., Romero, R., The ‘Great Obstetrical Syndromes’ are associated with disorders of deep placentation. Am. J. Obstet. Gynecol 204 (2011), 193–201.
4. Chazara, O., Moffett, A., Association of maternal KIR and fetal HLA-C genes with the risk of preeclampsia in the Chinese Han population. Placenta, 36, 2015, 967.
5. Cooley, S., Weisdorf, D.J., Guethlein, L.A., Klein, J.P., Wang, T., Marsh, S.G., Spellman, S., Haagenson, M.D., Saeturn, K., Ladner, M., Trachtenberg, E., Parham, P., Miller, J.S., Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. J. Immunol 192 (2014), 4592–4600.
6. Hiby, S.E., Walker, J.J., O'shaughnessy, K.M., Redman, C.W., Carrington, M., Trowsdale, J., Moffett, A., Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med 200 (2004), 957–965.
7. Hiby, S.E., Regan, L., Lo, W., Farrell, L., Carrington, M., Moffett, A., Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod 23 (2008), 972–976.
8. Hiby, S.E., Apps, R., Sharkey, A.M., Farrell, L.E., Gardner, L., Mulder, A., Claas, F.H., Walker, J.J., Redman, C.W., Morgan, L., Tower, C., Regan, L., Moore, G.E., Carrington, M., Moffett, A., Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest 120 (2010), 4102–4110.
9. Hiby, S.E., Apps, R., Chazara, O., Farrell, L.E., Magnus, P., Trogstad, L., Gjessing, H.K., Carrington, M., Moffett, A., Maternal KIR in combination with paternal HLA-C2 regulates human birth weight. J. Immunol 192 (2014), 5069–5073.
10. Karn, M.N., Penrose, L.S., Birth weight and gestation time in relation to maternal age, parity and infant survival. Ann. Eugen 16 (1951), 147–164.
11. Levron, Y., Dviri, M., Segol, I., Yerushalmi, G.M., Hourvitz, A., Orvieto, R., Mazaki-Tovi, S., Yinon, Y., The ‘immunologic theory’ of preeclampsia revisited: a lesson from donor oocyte gestations. Am. J. Obstet. Gynecol 211 (2014), e1–e5.
12. Lie, R.T., Rasmussen, S., Brunborg, H., Gjessing, H.K., Lie-Nielsen, E., Irgens, L.M., Fetal and maternal contributions to risk of preeclampsia: population based study. BMJ 316 (1998), 1343–1347.
13. Moffett, A., Colucci, F., Uterine NK cells: active regulators at the maternal-fetal interface. J. Clin. Invest 124 (2014), 1872–1879.
14. Moffett, A., Colucci, F., Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol. Rev 267 (2015), 283–297.
15. Moffett, A., Hiby, S., Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum. Reprod 24 (2009), 2048–2049.
16. Moffett, A., Hiby, S., Carrington, M., The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J. Reprod. Immunol 71 (2006), 132–133.
17. Nakimuli, A., Chazara, O., Hiby, S.E., Farrell, L., Tukwasibwe, S., Jayaraman, J., Traherne, J.A., Trowsdale, J., Colucci, F., Lougee, E., Vaughan, R.W., Elliott, A.M., Byamugisha, J., Kaleebu, P., Mirembe, F., Nemat-Gorgani, N., Parham, P., Norman, P.J., Moffett, A., A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), 845–850.
18. Saito, S., Takeda, Y., Sakai, M., Nakabayahi, M., Hayakawa, S., The incidence of pre-eclampsia among couples consisting of Japanese women and Caucasian men. J. Reprod. Immunol 70 (2006), 93–98.
19. Sharkey, A.M., Gardner, L., Hiby, S., Farrell, L., Apps, R., Masters, L., Goodridge, J., Lathbury, L., Stewart, C.A., Verma, S., Moffett, A., Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol 181 (2008), 39–46.
20. Stelma, F., Jansen, L., Sinnige, M.J., van Dort, K.A., Takkenberg, R.B., Janssen, H.L., Reesink, H.W., Kootstra, N.A., HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy. J. Viral Hepat, 2016, 10.1111/jvh.12525 Advance online publication.
21. Suppiah, V., Gaudieri, S., Armstrong, N.J., O'Connor, K.S., Berg, T., Weltman, M., Abate, M.L., Spengler, U., Bassendine, M., Dore, G.J., Irving, W.L., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D., Negro, F., Bochud, P.Y., Mallal, S., Ahlenstiel, G., Stewart, G.J., George, J., Booth, D.R., International Hepatitis C Genetics Consortium (IHCGC). IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. PLoS Med, 8, 2011, e1001092.
22. Trogstad, L.I., Eskild, A., Magnus, P., Samuelsen, S.O., Nesheim, B.I., Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. Int. J. Epidemiol 30 (2001), 1317–1322.
23. Xiong, S., Sharkey, A.M., Kennedy, P.R., Gardner, L., Farrell, L.E., Chazara, O., Bauer, J., Hiby, S.E., Colucci, F., Moffett, A., Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J. Clin. Invest 123 (2013), 4264–4672.
24. Yu, C.K., Smith, G.C., Papageorghiou, A.T., Cacho, A.M., Nicolaides, K.H., An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am. J. Obstet. Gynecol 193 (2005), 429–436.